NO992340L - Faste farmas°ytiske blandinger omfattende et cyklosporin og et anionisk overflateaktivt middel - Google Patents

Faste farmas°ytiske blandinger omfattende et cyklosporin og et anionisk overflateaktivt middel

Info

Publication number
NO992340L
NO992340L NO992340A NO992340A NO992340L NO 992340 L NO992340 L NO 992340L NO 992340 A NO992340 A NO 992340A NO 992340 A NO992340 A NO 992340A NO 992340 L NO992340 L NO 992340L
Authority
NO
Norway
Prior art keywords
cyclosporin
anionic surfactant
solid pharmaceutical
pharmaceutical compositions
disclosed
Prior art date
Application number
NO992340A
Other languages
English (en)
Other versions
NO992340D0 (no
Inventor
Bernard Charles Sherman
Original Assignee
Bernard Charles Sherman
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bernard Charles Sherman filed Critical Bernard Charles Sherman
Publication of NO992340D0 publication Critical patent/NO992340D0/no
Publication of NO992340L publication Critical patent/NO992340L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Transplantation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

Det beskrives en fast farmasøytisk blanding for peroral administrering, omfattende et cyklosporin og et anionisk overflateaktivt middel, fortrinnsvis natriumlaurylsulfat.
NO992340A 1997-09-16 1999-05-14 Faste farmas°ytiske blandinger omfattende et cyklosporin og et anionisk overflateaktivt middel NO992340L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NZ328751A NZ328751A (en) 1997-09-16 1997-09-16 Solid medicament containing an anionic surfactant and cyclosporin
PCT/CA1998/000880 WO1999013900A1 (en) 1997-09-16 1998-09-16 Solid pharmaceutical compositions comprising a cyclosporin and an anionic surfactant

Publications (2)

Publication Number Publication Date
NO992340D0 NO992340D0 (no) 1999-05-14
NO992340L true NO992340L (no) 1999-07-06

Family

ID=19926445

Family Applications (1)

Application Number Title Priority Date Filing Date
NO992340A NO992340L (no) 1997-09-16 1999-05-14 Faste farmas°ytiske blandinger omfattende et cyklosporin og et anionisk overflateaktivt middel

Country Status (23)

Country Link
US (1) US6197335B1 (no)
EP (1) EP0957931B1 (no)
JP (1) JP2001505928A (no)
KR (1) KR20000068991A (no)
CN (1) CN1239432A (no)
AR (1) AR013499A1 (no)
AT (1) ATE214938T1 (no)
AU (1) AU9149198A (no)
BR (1) BR9806212A (no)
CA (1) CA2271447A1 (no)
CZ (1) CZ157099A3 (no)
DE (1) DE69804429D1 (no)
HU (1) HUP0000839A3 (no)
ID (1) ID21683A (no)
IL (1) IL129780A0 (no)
NO (1) NO992340L (no)
NZ (1) NZ328751A (no)
PL (1) PL333353A1 (no)
SI (1) SI9820010A (no)
TR (1) TR199901070T1 (no)
WO (1) WO1999013900A1 (no)
YU (1) YU22399A (no)
ZA (1) ZA988452B (no)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5858401A (en) * 1996-01-22 1999-01-12 Sidmak Laboratories, Inc. Pharmaceutical composition for cyclosporines
US7732404B2 (en) * 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
GB0008785D0 (en) * 2000-04-10 2000-05-31 Novartis Ag Organic compounds
AR033711A1 (es) * 2001-05-09 2004-01-07 Novartis Ag Composiciones farmaceuticas
AR036852A1 (es) * 2001-10-19 2004-10-06 Isotechnika Inc Preconcentrado de una microemulsion de analogos de ciclosporina, su metodo de preparacion y metodos para producir inmunosupresion
GB0307403D0 (en) 2003-03-31 2003-05-07 Medical Res Council Selection by compartmentalised screening
US20060078893A1 (en) 2004-10-12 2006-04-13 Medical Research Council Compartmentalised combinatorial chemistry by microfluidic control
GB0307428D0 (en) 2003-03-31 2003-05-07 Medical Res Council Compartmentalised combinatorial chemistry
US20050059583A1 (en) 2003-09-15 2005-03-17 Allergan, Inc. Methods of providing therapeutic effects using cyclosporin components
US20050221339A1 (en) 2004-03-31 2005-10-06 Medical Research Council Harvard University Compartmentalised screening by microfluidic control
JP4521554B2 (ja) * 2004-03-31 2010-08-11 マイラン製薬株式会社 シクロスポリン製剤
US7968287B2 (en) 2004-10-08 2011-06-28 Medical Research Council Harvard University In vitro evolution in microfluidic systems
US7202209B2 (en) 2005-07-13 2007-04-10 Allergan, Inc. Cyclosporin compositions
US7276476B2 (en) * 2005-07-13 2007-10-02 Allergan, Inc. Cyclosporin compositions
US7297679B2 (en) 2005-07-13 2007-11-20 Allergan, Inc. Cyclosporin compositions
US20070015691A1 (en) 2005-07-13 2007-01-18 Allergan, Inc. Cyclosporin compositions
US7288520B2 (en) 2005-07-13 2007-10-30 Allergan, Inc. Cyclosporin compositions
US20070015693A1 (en) * 2005-07-13 2007-01-18 Allergan, Inc. Cyclosporin compositions
US7501393B2 (en) * 2005-07-27 2009-03-10 Allergan, Inc. Pharmaceutical compositions comprising cyclosporins
US9839667B2 (en) 2005-10-14 2017-12-12 Allergan, Inc. Prevention and treatment of ocular side effects with a cyclosporin
US7745400B2 (en) * 2005-10-14 2010-06-29 Gregg Feinerman Prevention and treatment of ocular side effects with a cyclosporin
US20100137163A1 (en) 2006-01-11 2010-06-03 Link Darren R Microfluidic Devices and Methods of Use in The Formation and Control of Nanoreactors
US9562837B2 (en) 2006-05-11 2017-02-07 Raindance Technologies, Inc. Systems for handling microfludic droplets
WO2007133710A2 (en) 2006-05-11 2007-11-22 Raindance Technologies, Inc. Microfluidic devices and methods of use thereof
WO2008021123A1 (en) 2006-08-07 2008-02-21 President And Fellows Of Harvard College Fluorocarbon emulsion stabilizing surfactants
US8772046B2 (en) 2007-02-06 2014-07-08 Brandeis University Manipulation of fluids and reactions in microfluidic systems
WO2008130623A1 (en) 2007-04-19 2008-10-30 Brandeis University Manipulation of fluids, fluid components and reactions in microfluidic systems
NZ586828A (en) * 2008-01-15 2012-12-21 Abbott Gmbh & Co Kg Powdered antibody compositions and methods of making same
JP2011514897A (ja) * 2008-03-04 2011-05-12 エフ．ホフマン−ラ ロシュ アーゲー 高濃度のミセル水溶液を調製する方法
EP2315629B1 (en) 2008-07-18 2021-12-15 Bio-Rad Laboratories, Inc. Droplet libraries
EP2411148B1 (en) 2009-03-23 2018-02-21 Raindance Technologies, Inc. Manipulation of microfluidic droplets
EP2486409A1 (en) 2009-10-09 2012-08-15 Universite De Strasbourg Labelled silica-based nanomaterial with enhanced properties and uses thereof
US10837883B2 (en) 2009-12-23 2020-11-17 Bio-Rad Laboratories, Inc. Microfluidic systems and methods for reducing the exchange of molecules between droplets
US10351905B2 (en) 2010-02-12 2019-07-16 Bio-Rad Laboratories, Inc. Digital analyte analysis
US9399797B2 (en) 2010-02-12 2016-07-26 Raindance Technologies, Inc. Digital analyte analysis
US9366632B2 (en) 2010-02-12 2016-06-14 Raindance Technologies, Inc. Digital analyte analysis
US8535889B2 (en) 2010-02-12 2013-09-17 Raindance Technologies, Inc. Digital analyte analysis
EP3447155A1 (en) 2010-09-30 2019-02-27 Raindance Technologies, Inc. Sandwich assays in droplets
EP3859011A1 (en) 2011-02-11 2021-08-04 Bio-Rad Laboratories, Inc. Methods for forming mixed droplets
WO2012112804A1 (en) 2011-02-18 2012-08-23 Raindance Technoligies, Inc. Compositions and methods for molecular labeling
EP3216872B1 (en) 2011-06-02 2020-04-01 Bio-Rad Laboratories, Inc. Enzyme quantification
US8841071B2 (en) 2011-06-02 2014-09-23 Raindance Technologies, Inc. Sample multiplexing
US8658430B2 (en) 2011-07-20 2014-02-25 Raindance Technologies, Inc. Manipulating droplet size
US11901041B2 (en) 2013-10-04 2024-02-13 Bio-Rad Laboratories, Inc. Digital analysis of nucleic acid modification
US9944977B2 (en) 2013-12-12 2018-04-17 Raindance Technologies, Inc. Distinguishing rare variations in a nucleic acid sequence from a sample
WO2015103367A1 (en) 2013-12-31 2015-07-09 Raindance Technologies, Inc. System and method for detection of rna species
JP6556753B2 (ja) * 2014-01-06 2019-08-07 アイアン・セラピューティクス・ホールディングス・アクチェンゲゼルシャフト トリマルトール鉄（ｉｉｉ）の投与計画
GB201418710D0 (en) 2014-10-21 2014-12-03 Iron Therapeutics Holdings Ag Dosage regimen
US10647981B1 (en) 2015-09-08 2020-05-12 Bio-Rad Laboratories, Inc. Nucleic acid library generation methods and compositions
CN111867594A (zh) * 2018-03-19 2020-10-30 大鹏药品工业株式会社 包含烷基硫酸钠的药物组合物
EP4166133A1 (en) * 2021-10-13 2023-04-19 Chugai Seiyaku Kabushiki Kaisha Composition containing peptide compound and surfactant

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7908722A (nl) 1979-12-03 1981-07-01 Naarden International Nv Werkwijze voor de bereiding van citrussap bevattende dranken met verbeterde troebelingsstabiliteit.
US5639724A (en) * 1984-07-24 1997-06-17 Sandoz Ltd. Cyclosporin galenic forms
JP2577049B2 (ja) 1987-06-04 1997-01-29 三共株式会社 シクロスポリン製剤
US5756450A (en) * 1987-09-15 1998-05-26 Novartis Corporation Water soluble monoesters as solubilisers for pharmacologically active compounds and pharmaceutical excipients and novel cyclosporin galenic forms
US5342625A (en) 1988-09-16 1994-08-30 Sandoz Ltd. Pharmaceutical compositions comprising cyclosporins
BE1003009A5 (fr) * 1989-02-09 1991-10-22 Sandoz Sa Nouvelles compositions pharmaceutiques a base de cyclosporines.
DD298351A5 (de) * 1989-11-06 1992-02-20 Jenapharm Gmbh,De Verfahren zur herstellung einer carrierabhaengigen arzneiform
JPH0597697A (ja) * 1991-10-02 1993-04-20 Lion Corp 歯槽骨再生剤
US5603955A (en) * 1994-07-18 1997-02-18 University Of Cincinnati Enhanced loading of solutes into polymer gels
IL116674A (en) * 1995-01-09 2003-05-29 Mendell Co Inc Edward Microcrystalline cellulose-based excipient having improved compressibility, pharmaceutical compositions containing the same and methods for the preparation of said excipient and of solid dosage form thereof
US5573783A (en) * 1995-02-13 1996-11-12 Nano Systems L.L.C. Redispersible nanoparticulate film matrices with protective overcoats
IE75744B1 (en) * 1995-04-03 1997-09-24 Elan Corp Plc Controlled release biodegradable micro- and nanospheres containing cyclosporin
IE80467B1 (en) * 1995-07-03 1998-07-29 Elan Corp Plc Controlled release formulations for poorly soluble drugs
JPH1059862A (ja) * 1996-08-16 1998-03-03 Meiji Seika Kaisha Ltd シクロスポリン製剤
US5891845A (en) * 1997-11-21 1999-04-06 Fuisz Technologies Ltd. Drug delivery systems utilizing liquid crystal structures

Also Published As

Publication number Publication date
WO1999013900A1 (en) 1999-03-25
YU22399A (sh) 2003-01-31
EP0957931A1 (en) 1999-11-24
NZ328751A (en) 1999-01-28
NO992340D0 (no) 1999-05-14
HUP0000839A2 (hu) 2000-11-28
KR20000068991A (ko) 2000-11-25
IL129780A0 (en) 2000-02-29
US6197335B1 (en) 2001-03-06
HUP0000839A3 (en) 2001-02-28
ID21683A (id) 1999-07-08
TR199901070T1 (xx) 1999-11-22
ZA988452B (en) 1999-03-30
CZ157099A3 (cs) 1999-09-15
PL333353A1 (en) 1999-12-06
CN1239432A (zh) 1999-12-22
CA2271447A1 (en) 1999-03-25
EP0957931B1 (en) 2002-03-27
SI9820010A (sl) 1999-08-31
ATE214938T1 (de) 2002-04-15
JP2001505928A (ja) 2001-05-08
AU9149198A (en) 1999-04-05
BR9806212A (pt) 2000-04-18
AR013499A1 (es) 2000-12-27
DE69804429D1 (de) 2002-05-02

Similar Documents

Publication Publication Date Title
NO992340L (no) Faste farmas°ytiske blandinger omfattende et cyklosporin og et anionisk overflateaktivt middel
LU91122I2 (fr) Efalizumab et ses dérivés pharmaceutiquement acceptables (raptiva).
DK0994710T3 (da) Farmaceutiske præparater til oral indgivelse omfattende en benzhydrylpiperazin og en cyclodextrin
NO20083842L (no) Anvendelse av opploselig lymfotoksin-beta-reseptor for fremstilling av medikamenter
BR0012908A (pt) Método para preparar uma composição oral estável antibacteriana contendo uma lupulona hidrogenada, e, composição oral estável antibacteriana
HUT74474A (en) Pharmaceutical emulsion comprising a short acting dihydropyridine type antihypertensive agent
BR9913737A (pt) Preparação farmacêutica
RS49723B (sr) Farmaceutska kompozicija koja sadrži entakapon ili nitekapon kao i umreženi derivat celuloze
TR199902175T2 (xx) Parasetamol i�eren yutma tableti.
BR0007294A (pt) Formulações farmacêuticas aperfeiçoadas
FI973691A (fi) Amlodipiinia tai sen suolaa tai felodipiinia ja ACE:n estäjää sisältäviä koostumuksia
ATE359793T1 (de) 2-methyl-thieno-benzodiazepin formulierung
PT1066304E (pt) Antagonistas macrolidos de lhrh
RS49889B (sr) Intraoralni ili intranazalni transmukozni preparat koji sadrži levosimendan
ATE213416T1 (de) Arzneizubereitungen enthaltend cefuroxim axetil
ES2191241T3 (es) Preparaciones farmaceuticas por via oral que comprenden s-(3-hidroxipropil)-l-cisteina.
HRP20000704B1 (en) Controlled release peroral compositions of levosimendan
DK1091750T3 (da) Cerebrospinalt og vaskulært farmaceutisk præparat og fremgangsmåde til fremstilling heraf
PT1299114E (pt) Composicao farmaceutica de diclofenac com base em vitamina e, papina e hialuronidase
ATE204286T1 (de) Modifizierte alpha-d-glcp-(1,2)-alpha-d-glcp-(1, 3)-alpha-d-glcp-analoge
ECSP982436A (es) Composicion
NO975526L (no) Nye laksativpreparater og fremgangsmåte for fremstilling av slike
GEU1999468Y (en) Medicinal Means Obtained from Motherwort

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application